Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01564069 · ClinicalTrials.gov registry record
Intrathecal Therapy for Chronic Non-Cancer Pain: An Analysis of Its Efficacy
A clinical trial, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 125
- Enrollment target
NCT01564069 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 125 participants.
The verdict
NCT01564069 has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 125 participants
- Enrollment target
Study Summary
Our hypothesis is that patients with intrathecal delivery systems for chronic non-cancer pain will report no improvement treatment efficacy when compared to patients with chronic pain managed with oral or systemic opioid therapies. Our secondary hypothesis is that patients with intrathecal delivery systems for chronic non-cancer pain will report no improvement in treatment efficacy when compared to patients with chronic pain who are managed with non-opioid therapies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2009-03-01 |
| Est. Completion | 2013-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01564069
The ClinicalTrials.gov registry entry for NCT01564069 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01564069 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01564069 about?
NCT01564069 is a clinical study titled "Intrathecal Therapy for Chronic Non-Cancer Pain: An Analysis of Its Efficacy". Our hypothesis is that patients with intrathecal delivery systems for chronic non-cancer pain will report no improvement treatment efficacy when compared to patients with chronic pain managed with oral or systemic opioid therapies. Our secondary hypothesis is that patients with intrathecal delivery ...
What is the current status of trial NCT01564069?
This trial is currently completed. The enrollment target is 125 participants. The study started on 2009-03-01. Estimated completion is 2013-03-31.
Who is sponsoring clinical trial NCT01564069?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.